1. Oxymatrine suppresses oral squamous cell carcinoma progression by suppressing CXC chemokine receptor 4 in an m6A modification decrease dependent manner
    Renhui Luo et al, 2022, Oncology Reports CrossRef
  2. The N-terminal polypeptide derived from viral macrophage inflammatory protein II reverses breast cancer epithelial-to-mesenchymal transition via a PDGFRα-dependent mechanism
    Qing-Ling Yang et al, 2017, Oncotarget CrossRef

  3. CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer


    Jiyang Xue et al, 2020, International Journal of Nanomedicine CrossRef
  4. CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy
    Ashraf Mousavi, 2020, Immunology Letters CrossRef
  5. Molecular Crosstalk between the Immunological Mechanism of the Tumor Microenvironment and Epithelial–Mesenchymal Transition in Oral Cancer
    Kaviyarasi Renu et al, 2022, Vaccines CrossRef
  6. Altered Immune-Related Gene Expressions Indicate Oral Cancer Nodal Disease
    K.Y.P. Liu et al, 2018, Journal of Dental Research CrossRef
  7. Pathological roles of the homeostatic chemokine CXCL12
    Rik Janssens et al, 2018, Cytokine & Growth Factor Reviews CrossRef
  8. Tumor‐associated neutrophils (TANs) in human carcinoma‐draining lymph nodes: a novel TAN compartment
    Silvia Lonardi et al, 2021, Clinical & Translational Immunology CrossRef
  9. Epithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities
    Zihang Ling et al, 2021, International Journal of Cancer CrossRef
  10. Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis
    Xutengyue Tian et al, 2022, Journal of Oncology CrossRef
  11. Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis
    Zhi Huang et al, 2019, European Journal of Medicinal Chemistry CrossRef
  12. Drug Delivery Systems in the Development of Novel Strategies for Glioblastoma Treatment
    Wiam El Kheir et al, 2022, Pharmaceutics CrossRef
  13. The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy
    Yu ZHOU et al, 2018, Chinese Journal of Natural Medicines CrossRef
  14. Inhibition of ITGB1 enhance the anti-tumor effect of cetuximab in colorectal cancer cell
    Xiaohui Yang et al, 2020, Medicine CrossRef
  15. MiR‐32‐5p promoted epithelial‐to‐mesenchymal transition of oral squamous cell carcinoma cells via regulating the KLF2/CXCR4 pathway
    Shi‐Yu Qin et al, 2022, The Kaohsiung Journal of Medical Sciences CrossRef
  16. Role of chemokine systems in cancer and inflammatory diseases
    Hongyi Li et al, 2022, MedComm CrossRef
  17. CXCR4 enhances cisplatin resistance of human tongue squamous cell carcinoma
    Xiu‐Mei Zhuang et al, 2019, Journal of Oral Pathology & Medicine CrossRef